Combined administration with DNA encoding vesicular stomatitis virus G protein enhances DNA vaccine potency

Journal of Virology

Volumn 84, Issue 5, 2010, Pages 2331-2339

  Mao, Chih Ping ^a   Hung, Chien Fu ^a   Kang, Tae Heung ^a   He, Liangmei ^a   Tsai, Ya Chea ^a   Wu, Chao Yi ^a   Wu, T C ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; DNA VACCINE; FUSOGENIC MEMBRANE GLYCOPROTEIN; PLASMID VECTOR; PROTEIN E7; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER INHIBITION; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; CROSS PRESENTATION; DENDRITIC CELL; DNA IMMUNIZATION; DRUG DESIGN; DRUG POTENCY; DRUG POTENTIATION; ELECTROPORATION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; VESICULAR STOMATITIS VIRUS;

ANIMALS; ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; CELL DEATH; CELL FUSION; CELLS, CULTURED; DENDRITIC CELLS; DNA, VIRAL; FEMALE; HUMANS; INTERFERON-GAMMA; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MUSCLE, SKELETAL; NEOPLASM TRANSPLANTATION; ONCOGENE PROTEINS, VIRAL; TRANSFECTION; VACCINES, DNA; VIRAL ENVELOPE PROTEINS;

HARNESS; HUMAN PAPILLOMAVIRUS TYPE 16; MUS; VESICULAR STOMATITIS VIRUS;

EID: 77649223097     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01954-09     Document Type: Article

References (30)

1. . Bateman, A., F. Bullough, S. Murphy, L. Emiliusen, D. Lavillette, F. L. Cosset, R. Cattaneo, S. J. Russell, and R. G. Vile. 2000. Fusogenic membrane glycoproteins as a novel class of genes for the local and immune-mediated control of tumor growth. Cancer Res. 60:1492-1497.
2. . Bateman, A. R., K. J. Harrington, T. Kottke, A. Ahmed, A. A. Melcher, M. J. Gough, E. Linardakis, D. Riddle, A. Dietz, C. M. Lohse, S. Strome, T. Peterson, R. Simari, and R. G. Vile. 2002. Viral fusogenic membrane glycoproteins kill solid tumor cells by nonapoptotic mechanisms that promote cross presentation of tumor antigens by dendritic cells. Cancer Res. 62:6566-6578.
3. . Bettelli, E., T. Korn, M. Oukka, and V. K. Kuchroo. 2008. Induction and effector functions of T(H)17 cells. Nature 453:1051-1057.
4. . Boyer, J. D., T. M. Robinson, M. A. Kutzler, R. Parkinson, S. A. Calarota, M. K. Sidhu, K. Muthumani, M. Lewis, G. Pavlakis, B. Felber, and D. Weiner. 2005. SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques. J. Med. Primatol. 34:262-270.
5. . Brandsma, J. L., M. Shlyankevich, L. Buonocore, A. Roberts, S. M. Becker, and J. K. Rose. 2007. Therapeutic efficacy of vesicular stomatitis virus-based E6 vaccination in rabbits. Vaccine 25:751-762.
6. . Brandsma, J. L., M. Shlyankevich, Y. Su, D. Zelterman, J. K. Rose, and L. Buonocore. 14 July 2009. Reversal of papilloma growth in rabbits therapeutically vaccinated against E6 with naked DNA and/or vesicular stomatitis virus vectors. Vaccine. [Epub ahead of print.]
7. . Brandsma, J. L., M. Shylankevich, Y. Su, A. Roberts, J. K. Rose, D. Zelterman, and L. Buonocore. 2007. Vesicular stomatitis virus-based therapeutic vaccination targeted to the E1, E2, E6, and E7 proteins of cottontail rabbit papillomavirus. J. Virol. 81:5749-5758.
8. + T cells: when, where, and how. Annu. Rev. Immunol. 24:519-540.
9. . Chen, C. H., T. L. Wang, C. F. Hung, Y. Yang, R. A. Young, D. M. Pardoll, and T. C. Wu. 2000. Enhancement of DNA vaccine potency by linkage of antigen gene to an HSP70 gene. Cancer Res. 60:1035-1042.
10. . Cheng, W. F., C. F. Hung, C. Y. Chai, K. F. Hsu, L. He, M. Ling, and T. C. Wu. 2001. Tumor-specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Clin. Invest. 108:669-678.
11. . Fu, T. M., J. B. Ulmer, M. J. Caulfield, R. R. Deck, A. Friedman, S. Wang, X. Liu, J. J. Donnelly, and M. A. Liu. 1997. Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes. Mol. Med. 3:362-371.
12. . Hung, C. F., W. F. Cheng, K. F. Hsu, C. Y. Chai, L. He, M. Ling, and T. C. Wu. 2001. Cancer immunotherapy using a DNA vaccine encoding the translocation domain of a bacterial toxin linked to a tumor antigen. Cancer Res. 61:3698-3703.
13. . Kazama, H., J. E. Ricci, J. M. Herndon, G. Hoppe, D. R. Green, and T. A. Ferguson. 2008. Induction of immunological tolerance by apoptotic cells requires caspase-dependent oxidation of high-mobility group box-1 protein. Immunity 29:21-32.
14. . Kim, J. W., C. F. Hung, J. Juang, L. He, T. W. Kim, D. K. Armstrong, S. I. Pai, P. J. Chen, C. T. Lin, D. A. Boyd, and T. C. Wu. 2004. Comparison of HPV DNA vaccines employing intracellular targeting strategies. Gene Ther. 11:1011-1018.
15. . Kutzler, M. A., and D. B. Weiner. 2008. DNA vaccines: ready for prime time? Nat. Rev. Genet. 9:776-788.
16. . Lin, K. Y., F. G. Guarnieri, K. F. Staveley-O'Carroll, H. I. Levitsky, J. T. August, D. M. Pardoll, and T. C. Wu. 1996. Treatment of established tumors with a novel vaccine that enhances major histocompatibility class II presentation of tumor antigen. Cancer Res. 56:21-26.
17. . Quinonez, R., and R. E. Sutton. 2002. Lentiviral vectors for gene delivery into cells. DNA Cell Biol. 21:937-951.
18. . Reis e Sousa, C. 2001. Dendritic cells as sensors of infection. Immunity 14:495-498.
19. . Reuter, J. D., B. E. Vivas-Gonzalez, D. Gomez, J. H. Wilson, J. L. Brandsma, H. L. Greenstone, J. K. Rose, and A. Roberts. 2002. Intranasal vaccination with a recombinant vesicular stomatitis virus expressing cottontail rabbit papillomavirus L1 protein provides complete protection against papillomavirus-induced disease. J. Virol. 76:8900-8909.
20. . Roberts, A., J. D. Reuter, J. H. Wilson, S. Baldwin, and J. K. Rose. 2004. Complete protection from papillomavirus challenge after a single vaccination with a vesicular stomatitis virus vector expressing high levels of L1 protein. J. Virol. 78:3196-3199.
21. . Rosati, M., C. Bergamaschi, A. Valentin, V. Kulkarni, R. Jalah, C. Alicea, V. Patel, A. S. von Gegerfelt, D. C. Montefiori, D. J. Venzon, A. S. Khan, R. Draghia-Akli, K. K. Van Rompay, B. K. Felber, and G. N. Pavlakis. 2009. DNA vaccination in rhesus macaques induces potent immune responses and decreases acute and chronic viremia after SIVmac251 challenge. Proc. Natl. Acad. Sci. U. S. A. 106:15831-15836.
22. . Rosati, M., A. Valentin, R. Jalah, V. Patel, A. von Gegerfelt, C. Bergamaschi, C. Alicea, D. Weiss, J. Treece, R. Pal, P. D. Markham, E. T. Marques, J. T. August, A. Khan, R. Draghia-Akli, B. K. Felber, and G. N. Pavlakis. 2008. Increased immune responses in rhesus macaques by DNA vaccination combined with electroporation. Vaccine 26:5223-5229.
23. . Rosati, M., A. von Gegerfelt, P. Roth, C. Alicea, A. Valentin, M. Robert-Guroff, D. Venzon, D. C. Montefiori, P. Markham, B. K. Felber, and G. N. Pavlakis. 2005. DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge. J. Virol. 79:8480-8492.
24. . Sancho, D., O. P. Joffre, A. M. Keller, N. C. Rogers, D. Martinez, P. Hernanz-Falcon, I. Rosewell, and C. Reis e Sousa. 2009. Identification of a dendritic cell receptor that couples sensing of necrosis to immunity. Nature 458:899-903.
25. . Sauter, B., M. L. Albert, L. Francisco, M. Larsson, S. Somersan, and N. Bhardwaj. 2000. Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells. J. Exp. Med. 191:423-434.
26. . Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class I and class II molecules. J. Immunol. 158:2723-2730.
27. . Stewart, S. A., D. M. Dykxhoorn, D. Palliser, H. Mizuno, E. Y. Yu, D. S. An, D. M. Sabatini, I. S. Chen, W. C. Hahn, P. A. Sharp, R. A. Weinberg, and C. D. Novina. 2003. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 9:493-501.
28. + cervical intraepithelial neoplasia 2/3. Clin. Cancer Res. 15:361-367.
29. . von Gegerfelt, A. S., M. Rosati, C. Alicea, A. Valentin, P. Roth, J. Bear, G. Franchini, P. S. Albert, N. Bischofberger, J. D. Boyer, D. B. Weiner, P. Markham, Z. R. Israel, J. H. Eldridge, G. N. Pavlakis, and B. K. Felber. 2007. Long-lasting decrease in viremia in macaques chronically infected with simian immunodeficiency virus SIVmac251 after therapeutic DNA immunization. J. Virol. 81:1972-1979.
30. . Wolfers, J., A. Lozier, G. Raposo, A. Regnault, C. Thery, C. Masurier, C. Flament, S. Pouzieux, F. Faure, T. Tursz, E. Angevin, S. Amigorena, and L. Zitvogel. 2001. Tumor-derived exosomes are a source of shared tumor rejection antigens for CTL cross-priming. Nat. Med. 7:297-303.